ILYM20053 / KT-US-499-0150 / Reagan
Basic Study Information
Purpose:
The goal of this clinical study is to learn more about the safety and dosing of the
study drugs, KITE-363 and KITE-753, in participants with relapsed and/or refractory
B-cell lymphoma.
Location: University of Rochester Medical Center
Lead Researcher (Principal Investigator)
Lead Researcher:
Patrick Reagan
Study Contact Information
Study Contact: Clinical Trials Office
Study Location: Wilmot Cancer Institute, University of Rochester Medical Center
Study Email: WCICTOResearch@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search